1 Health System Reform in China 6 Reform of how health care is paid for in China: challenges and oppor..
来源:LANCET( P 0140-6736 E 1474-547X ) 发表时间: 2008/11
类型:期刊论文 为本人加分:46480.476788
贡献度:单独第一作者
2 A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators
来源:APPL HEALTH ECON HEA( P 1175-5652 E 1179-1896 ) 发表时间: 2015/08
类型:期刊论文 为本人加分:2388.925016
贡献度:单独第一作者;单独通讯作者
3 Pharmaceutical cost-containment policy: experiences in Shanghai, China
来源:HEALTH POLICY PLANN( P 0268-1080 E ) 发表时间: 2001/12
类型:期刊论文 为本人加分:1993.908904
贡献度:单独第一作者;单独通讯作者
4 factors associated with the decline of the cooperative medical system and barefoot doctors in rural ..
来源:B WORLD HEALTH ORGAN( P 0042-9686 E ) 发表时间: 1989/01
类型:期刊论文 为本人加分:1603.920046
贡献度:单独通讯作者
5 Estimated public health impact of nationwide vaccination of infants with 7-valent pneumococcal conju..
来源:INT J INFECT DIS( P 1201-9712 E 1878-3511 ) 发表时间: 2014/09
类型:期刊论文 为本人加分:1175.490142
贡献度:单独第一作者
6 Early appraisal of China's huge and complex health-care reforms
来源:LANCET( P 0140-6736 E 1474-547X ) 发表时间: 2012/03
类型:期刊论文 为本人加分:1058.975029
贡献度:参与作者
7 Overview on social security system of rare diseases in China
来源:BIOSCI TRENDS( P 1881-7815 E 1881-7823 ) 发表时间: 2019/08
类型:期刊论文 为本人加分:1047.851449
贡献度:共同通讯作者
8 Health-care systems and pharmacoeconomic research in Asia-Pacific region
来源:VALUE HEALTH( P 1098-3015 E 1524-4733 ) 发表时间: 2008/03
类型:期刊论文 为本人加分:935.435375
9 Hepatitis C virus cure with direct acting antivirals: Clinical economic, societal and patient value ..
来源:WORLD J HEPATOL( P 1948-5182 E ) 发表时间: 2019/05
类型:期刊论文 为本人加分:919.316665
贡献度:单独通讯作者
10 Memantine for treatment of moderate or severe Alzheimer's disease patients in urban China: clini..
来源:EXPERT REV PHARM OUT( P 1473-7167 E 1744-8379 ) 发表时间: 2015/08
类型:期刊论文 为本人加分:682.219062
贡献度:单独第一作者;单独通讯作者